| K-number | K192138 |
| Device name | Rejuvapen NXT |
| Applicant | Refine USA, LLC |
| Product code | QAI |
| Device class | Class II |
| Decision date | Apr 9, 2020 |
| Decision | Substantially Equivalent |
| Regulation | 878.4430 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov